Epstein-Barr virus detection in endoscopic submucosal dissection-proven early gastric cancer with mixed-type histology

Cancer Rep (Hoboken). 2023 May;6(5):e1730. doi: 10.1002/cnr2.1730. Epub 2022 Nov 24.

Abstract

Backgrounds: Early gastric cancer (EGC) with mixed-type histology is a significant risk factor for additional surgery after endoscopic submucosal dissection (ESD). On the other hand, Epstein-Barr virus-associated gastric cancer (EBVaGC) with mixed-type histology is a favorable risk factor with regard to lymph node metastasis.

Methods: We performed EBV detection in 13 ESD-proven lesions in 13 cases of early gastric cancer with mixed-type histology using EBV-encoded small RNA1 in situ hybridization (EBER1 ISH).

Results: EBVaGC was diagnosed in only one (7.7%) of the tested lesions. That EBVaGC patient underwent surgery and there was no residual lesion and no lymph metastasis. EBVaGC is not frequent in EGC with mixed-type histology.

Conclusions: EBV testing of gastric biopsy specimens seems not to be useful to predict the mixed-type histology results of ESD. However, EBV testing for ESD specimens of EGC with mixed-type histology is expected to be useful for avoiding excessive additional surgery.

Keywords: Epstein-Barr virus-associated gastric cancer; endoscopic submucosal dissection; gastric cancer with mixed-type histology.

MeSH terms

  • Endoscopic Mucosal Resection* / methods
  • Epstein-Barr Virus Infections* / diagnosis
  • Herpesvirus 4, Human / genetics
  • Humans
  • Risk Factors
  • Stomach Neoplasms* / diagnosis
  • Stomach Neoplasms* / pathology
  • Stomach Neoplasms* / surgery